Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. The company is headquartered in Fishers, Indiana. The company went IPO on 2016-06-23. The firm is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The firm's business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The firm is engaged in the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers. The company sells products in bulk to companies who may use the Company's products as ingredients in their products or sell the products they purchase from the Company to their own customers.
ACBM stock price ended at $0.03 on 月曜日, after rising 0.00%
On the latest trading day Mar 23, 2026, the stock price of ACBM rose by 0.00%, climbing from $0.10 to $0.03. Throughout the session, the stock experienced a volatility of 233.33%, with prices fluctuating between a daily low of $0.03 and a high of $0.10. Alongside this price increase, trading volume also rose by 120 shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 387 shares were traded, amounting to a market value of approximately $1.8M.